Want to join the conversation?
Andrew Kaplowitz from Citigroup asks about GM, if backlog GM is more than the revenue GM. $JEC said that in this environment the company is more focused on strengthening the mix of its backlog going forward rather than chasing low value business that is not going to play out good for $JEC. And on GM, the backlog GM is better.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?